Skip to main content
Search hero banner

Search results

Showing 1 - 12 of 12 results

Safeguarding the future of nuclear medicine production

Safeguarding the future of Australia's nuclear medicine

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Gamma spectrometry

Radioactivity Measurement

ANSTO has responsibilities mandated by the Australian Government for the maintenance of the national measurement standard for radioactivity.

OPAL Reactor Core

What are radioisotopes?

Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.

ansto-gentech-generator

Nuclear medicine processing and distribution

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

ANSTO reports

Report to the independent nuclear regulator, ARPANSA, and the IAEA

Governance at ANSTO

Governance

ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.

Pagination